NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces the closing of a private placement of common stock and warrants with accredited investors, raising gross proceeds of $2.4 million.
June 26, 2019
· 3 min read